Results 51 to 60 of about 260,266 (297)

Innovating Firms and Aggregate Innovation [PDF]

open access: yesJournal of Political Economy, 2002
We develop a parsimonious model of innovation to confront firmlevel evidence. It captures the dynamics of individual heterogeneous firms, describes the behavior of an industry with firm entry and exit, and delivers a general equilibrium model of technological change.
Klette, Tor Jakob, Kortum, Samuel
openaire   +6 more sources

Cell wall target fragment discovery using a low‐cost, minimal fragment library

open access: yesFEBS Letters, EarlyView.
LoCoFrag100 is a fragment library made up of 100 different compounds. Similarity between the fragments is minimized and 10 different fragments are mixed into a single cocktail, which is soaked to protein crystals. These crystals are analysed by X‐ray crystallography, revealing the binding modes of the bound fragment ligands.
Kaizhou Yan   +5 more
wiley   +1 more source

Green consumption: the role of perceived symbolic value and personal innovativeness [PDF]

open access: yesJournal of Responsible Production and Consumption
Purpose – This study aims to explore the relationship between personal innovativeness, perceived symbolic value and green purchase intentions within the context of sustainable consumption.
Albert Hasudungan   +1 more
doaj   +1 more source

Integrating technology acceptance model and organizational innovativeness in the adoption of mobile commerce [PDF]

open access: yesManagement Science Letters, 2017
The primary objective of this paper is to consider the influence of perceived usefulness, per-ceived ease of use, business innovativeness and product innovativeness on the adoption of mo-bile commerce. For the model of this study to be tested empirically,
Maruf Gbadebo Salimon   +3 more
doaj   +1 more source

β‐TrCP overexpression enhances cisplatin sensitivity by depleting BRCA1

open access: yesMolecular Oncology, EarlyView.
Low levels of β‐TrCP (Panel A) allow the accumulation of BRCA1 and CtIP, which facilitate the repair of cisplatin‐induced DNA damage via homologous recombination (HR) and promote tumor cell survival. In contrast, high β‐TrCP expression (Panel B) leads to BRCA1 and CtIP degradation, impairing HR repair, resulting in persistent DNA damage and apoptosis ...
Rocío Jiménez‐Guerrero   +8 more
wiley   +1 more source

ENHANCED MANAGEMENT TOOLS FOR DEVELOPING ENTERPRISE INNOVATIVENESS

open access: yesResearch on Enterprise in Modern Economy Theory and Practice, 2018
Sustainable socio-economic development of a country depends on the competitiveness of enterprises, a key factor of which is continuous development of innovativeness.
Alena Apiakun
doaj   +1 more source

Characterizing the salivary RNA landscape to identify potential diagnostic, prognostic, and follow‐up biomarkers for breast cancer

open access: yesMolecular Oncology, EarlyView.
This study explores salivary RNA for breast cancer (BC) diagnosis, prognosis, and follow‐up. High‐throughput RNA sequencing identified distinct salivary RNA signatures, including novel transcripts, that differentiate BC from healthy controls, characterize histological and molecular subtypes, and indicate lymph node involvement.
Nicholas Rajan   +9 more
wiley   +1 more source

What contributes to individual innovativeness? A multilevel perspective

open access: yesInternational Journal of Innovation Studies, 2019
It is well-established that individual innovativeness is an indispensable quality for employees working in a variety of workplace environments. However, the interaction between the psychological and organizational factors influencing innovativeness ...
Tahani Z. Aldahdouh   +2 more
doaj   +1 more source

Bridging the gap: Multi‐stakeholder perspectives of molecular diagnostics in oncology

open access: yesMolecular Oncology, EarlyView.
Although molecular diagnostics is transforming cancer care, implementing novel technologies remains challenging. This study identifies unmet needs and technology requirements through a two‐step stakeholder involvement. Liquid biopsies for monitoring applications and predictive biomarker testing emerge as key unmet needs. Technology requirements vary by
Jorine Arnouts   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy